Achyut Healthcare Limited

Equities

543499

INE0K1401012

Pharmaceuticals

Market Closed - Bombay S.E. 11:00:55 26/06/2024 BST 5-day change 1st Jan Change
50.13 INR +7.78% Intraday chart for Achyut Healthcare Limited -7.17% -13.57%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Achyut Healthcare Turns to Profit in Fiscal Q4 MT
Achyut Healthcare Limited announced that it has received INR 157.248 million in funding CI
Achyut Healthcare Limited announced that it expects to receive INR 205.758 million in funding CI
Achyut Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Achyut Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Achyut Healthcare Limited Announces Appointment of Company Secretary and Compliance Officer CI
3,592,800 Equity Shares of Achyut Healthcare Limited are subject to a Lock-Up Agreement Ending on 25-MAR-2023. CI
Achyut Healthcare Board to Consider Issuance of Bonus Shares MT
Achyut Healthcare to Allot Nearly 3 Million Shares to Promoters, Non-Promoters MT
Achyut Healthcare Limited announced that it has received INR 52.08 million in funding from Ray Remedies Private Limited, Sera Investments & Finance India Limited, Everon Advisors Private Limited CI
Achyut Healthcare Limited announced that it expects to receive funding CI
Parag Sandip Kumar Dave Resigns as Company Secretary Cum Compliance Officers of Achyut Healthcare CI
Achyut Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2022 CI
Achyut Healthcare Limited has completed an IPO in the amount of INR 36 million. CI
Achyut Healthcare Limited has filed an IPO. CI
Chart Achyut Healthcare Limited
More charts
Achyut Healthcare Limited is an India-based pharmaceutical trading company. The Company is focused on dealing in active pharmaceutical ingredients (API), pharmaceutical products, and medical devices. The Company is engaged in the business of pharmaceutical formulations in the forms of tablets, capsules, oral liquid and injectable. The Company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.
More about the company
  1. Stock Market
  2. Equities
  3. 543499 Stock
  4. News Achyut Healthcare Limited
  5. Achyut Healthcare Board to Consider Issuance of Bonus Shares